These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8100171)

  • 41. Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate.
    Kastin AJ; Hahn K; Zadina JE; Banks WA; Hackler L
    J Neurochem; 1995 Apr; 64(4):1855-9. PubMed ID: 7891114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells.
    Harrison LM; Kastin AJ; Zadina JE
    J Pharmacol Exp Ther; 1998 Feb; 284(2):611-7. PubMed ID: 9454805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Gergen KA; Chang SL; Niu YF; Kastin AJ; Zadina JE
    Peptides; 1994; 15(8):1505-11. PubMed ID: 7700853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Pro-Leu-Gly-NH2 (MIF) on the antinociceptive and thermoregulatory actions of morphine and oxotremorine.
    Slater P; Dickinson SL
    J Pharm Pharmacol; 1982 Feb; 34(2):113-5. PubMed ID: 6121869
    [No Abstract]   [Full Text] [Related]  

  • 45. Tyr-MIF-1 augments benzodiazepine receptor binding in vivo.
    Miller LG; Kastin AJ; Greenblatt DJ
    Pharmacol Biochem Behav; 1987 Dec; 28(4):521-4. PubMed ID: 2893390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of Tyr-MIF-1 to isolated brain capillaries.
    Pretorius HT; Kastin AJ; Banks WA
    Brain Res Bull; 1986 Dec; 17(6):829-31. PubMed ID: 2879616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some analogs of Tyr-MIF-1 affect passive avoidance behavior but not motor activity in rats.
    Hayashi T; Fischman AJ; Kastin AJ; Coy DH
    Pharmacol Biochem Behav; 1984 Nov; 21(5):809-12. PubMed ID: 6151198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age- and sex-related changes in Tyr-MIF-1-like immunoreactivity in rat plasma.
    Kastin AJ; Fabre L; Brown MM; Olson RD
    Neuroendocrinology; 1992 Dec; 56(6):902-6. PubMed ID: 1369600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid from morphine-dependent rats precipitates opiate abstinence syndrome.
    Malin DH; Harter L; Jenkins PD; Monfort RD; Bruce PD; Farley PA; Ferebee R; Thrasher KL; Marullo DS
    Life Sci; 1987 Jul; 41(3):377-83. PubMed ID: 3600184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naloxone, but not Tyr-MIF-1, reduces volitional ethanol drinking in rats: correlation with degree of spontaneous preference.
    Pulvirenti L; Kastin AJ
    Pharmacol Biochem Behav; 1988 Sep; 31(1):129-34. PubMed ID: 2908062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat.
    Malin DH; Lake JR; Fowler DE; Hammond MV; Brown SL; Leyva JE; Prasco PE; Dougherty TM
    Peptides; 1990; 11(2):277-80. PubMed ID: 2356156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MIF-1 and Tyr-MIF-1 antagonize morphine and opioid but not non-opioid stress-induced analgesia in the snail, Cepaea nemoralis.
    Kavaliers M
    Peptides; 1987; 8(1):1-5. PubMed ID: 2883631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Tyr-MIF-1 family of peptides.
    Reed GW; Olson GA; Olson RD
    Neurosci Biobehav Rev; 1994; 18(4):519-25. PubMed ID: 7708364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study.
    Bhargava HN
    Br J Pharmacol; 1981 Apr; 72(4):707-14. PubMed ID: 6116510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex differences in naloxone- and Tyr-MIF-1-induced hypoalgesia.
    Kavaliers M; Innes DG
    Peptides; 1993; 14(5):1001-4. PubMed ID: 7904339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
    Mycroft FJ; Bhargava HN; Wei ET
    Peptides; 1987; 8(6):1051-5. PubMed ID: 2894644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central administration of Tyr-MIF-1 stimulates gastrointestinal motility in rats: evidence for the involvement of dopamine, sigma and CCK receptors.
    Million M; Fioramonti J; Bueno L
    Neuropeptides; 1994 Feb; 26(2):77-85. PubMed ID: 7909585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.
    Kastin AJ; Schwartzenburg D; Tsui L; Miller LG; Olson GA; Olson RD
    Brain Res Bull; 1989 Dec; 23(6):443-6. PubMed ID: 2575442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
    Banks WA; Kastin AJ; Ehrensing CA
    J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MIF-1 and Tyr-MIF-1 fail to alter benzodiazepine-induced hypothermia.
    Kastin AJ; Miller LG; Schwartzenburg DS
    Pharmacol Biochem Behav; 1989 May; 33(1):261-3. PubMed ID: 2571169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.